Insight

Insight creates conversation to build community, exploring issues and events that connect people in our region. Insight covers breaking news and big ideas, music, arts & culture with responsible journalism, civil discussion and diverse voices.

Schedule

Monday – Thursday, 9 a.m. – 10 a.m.
on News Station

 We Get Support From:
Become a Supporter 
 We Get Support From:
Become a Supporter 

COVID-19 Drug ‘Remdesivir’ Concerns, Potential

Monday, May 11, 2020 | Sacramento, CA
CDC via AP

This illustration provided by the Centers for Disease Control and Prevention (CDC) in January 2020 shows the 2019 Novel Coronavirus (2019-nCoV).

CDC via AP

Remdesivir is a drug in clinical trials showing promise in reducing the severity of COVID-19 in those infected. 

It was recently approved by the U.S. FDA, and the government has said it's distributing the promising coronavirus drug to the hardest-hit areas of the country. Eventually, all 50 states will get it. 

We take a closer look at Remdesivir and its prospects as a longterm solution to the coronavirus.  

Guests
  • UC Davis School of Veterinary Medicine Distinguished Professor Emeritus Dr. Niels Pedersen

Back to Top